MedPath

Effect of drugs Ketofol versus Fentanyl and Midazolam for sedation on Brain injury markers in traumatic Brain Injury Patients in IC

Phase 4
Conditions
Health Condition 1: - Health Condition 2: S069- Unspecified intracranial injury
Registration Number
CTRI/2024/03/064037
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Severe traumatic brain injury patients admitted into Neuro Trauma ICU within 48 hours after the trauma.

1)Patients with a primary diagnosis of isolated severe TBI GCS 3-8

2) Patients between 18-65 years of age and of either sex

Exclusion Criteria

1)Patients with persistent GCS of 3 with bilateral fixed dilated pupils after initial resuscitation.

2)Also includes those patients who underwent decompressive craniectomy before ICU admission

3)In the absence of a guardian to give consent for the study

4)Life-threatening polytrauma

4) Patients in shock requiring vasopressor support at ICU admission

5) Pre-existing brain disease

6) Pregnancy

7) Patients allergic to drugs being used for sedation

8) Patients with deranged hepatic and renal parameters

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the levels GFAP and UCH L1 levels after 48 hrs of ICU admission using ketofol versus fentanyl and midazolam as sedationTimepoint: To compare the levels GFAP and UCH L1 levels after 48 hrs of ICU admission using ketofol versus fentanyl and midazolam as sedation
Secondary Outcome Measures
NameTimeMethod
To compare the levels GFAP and UCH L1 levels after 5 days of ICU admission <br/ ><br>2) Duration of ICU and Hospital stay <br/ ><br> <br/ ><br>Timepoint: after 5 days of ICU admission
© Copyright 2025. All Rights Reserved by MedPath